Custom immune cells take on advanced colorectal cancer in new trial
Disease control
Recruiting now
This early-stage study is testing a new personalized treatment called iNeo-Vac-T01 for people with advanced colorectal cancer that hasn't responded to standard therapies. The treatment uses a patient's own immune cells, which are specially trained in the lab to recognize and atta…
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC